Presentation TCT 2021 Oral Anticoagulation Should Be the Default Strategy After LAAC Presenter: Matthew J. Price November 06, 2021
Presentation TCT 2021 PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation Presenter: Pavel Osmancik November 05, 2021
Presentation TVT 2021 Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Presenter: Yousif Ahmad July 22, 2021